drugset / Trial / NCT04455243
Inflammatory Regulation Effect of NAC on COVID-19 Treatment
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Study times to evaluate the efficacy of N-Acetylcysteine therapy in the management of adult admitted patients with COVID-19.
Timeline
- Start
- 2020-08-01
- Primary completion
- 2021-08-30
- Completion
- 2021-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | N-acetylcysteine | Small molecule | 150 mg/kg | Oral |